Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on GSK2190915 versus montelukast versus placebo with fluticasone propionate/salmeterol in uncontrolled adult asthma
2010-019989-91Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fiboflapon in asthma (3 arms), sponsored by GSK. Primary endpoint: Trough FEV1 at end of treatment period. Started Sep 2010; status: completed.
02
Drugs
fiboflapon
03
Conditions
asthma
Beyond the preview
Go deeper on 2010-019989-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019989-91.